Clincosm LogoSign in Get a demo

Major Depressive Disorder

Showing NaN - NaN of 78
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDD Trial in United States (REL-1017, Placebo)

Recruiting
  • Major Depressive Disorder
  • Saraland, Alabama
  • +46 more
Jan 18, 2023

MDD Trial in United States (SAGE-217, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • Rogers, Arkansas
  • +52 more
Nov 22, 2022

Migraine, MDD Trial in Worldwide (Fremanezumab, Placebo)

Completed
  • Migraine
  • Major Depressive Disorder
  • Little Rock, Arkansas
  • +63 more
Dec 7, 2022

MDD, Insomnia Trial in United States (SAGE-217, Placebo)

Terminated
Has Results
  • Major Depressive Disorder
  • Insomnia
  • Little Rock, Arkansas
  • +27 more
Oct 13, 2022

MDD, Treatment Resistant Depression, Depression Trial in United States (AXS-05)

Completed
Has Results
  • Major Depressive Disorder
  • +2 more
  • AXS-05 (dextromethorphan and bupropion) oral tablets
  • Phoenix, Arizona
  • +50 more
Sep 16, 2022

MDD Trial in United States (XEN1101 10 mg, XEN1101 20 mg, Placebo)

Recruiting
  • Major Depressive Disorder
  • XEN1101 10 mg
  • +2 more
  • Lafayette, California
  • +5 more
Jul 11, 2022

MDD Trial in United States (SP-624, Placebo)

Active, not recruiting
  • Major Depressive Disorder
  • Phoenix, Arizona
  • +38 more
May 13, 2022

MDD Trial in United States (Lumateperone, Placebo)

Recruiting
  • Major Depressive Disorder
  • Little Rock, Arkansas
  • +16 more
Apr 7, 2022

MDD Trial in Worldwide (Lumateperone)

Enrolling by invitation
  • Major Depressive Disorder
  • Phoenix, Arizona
  • +44 more
Apr 7, 2022

MDD Trial in Canada, United States (PNB01 fixed dose combination of pipamperone and citalopram, Citalopram, Pipamperone)

Completed
Has Results
  • Major Depressive Disorder
  • PNB01 fixed dose combination of pipamperone and citalopram
  • +2 more
  • Glendale, California
  • +30 more
Mar 14, 2022

PTSD, MDD Trial in San Diego (Behavioral Activation, Cognitive Processing Therapy)

Active, not recruiting
  • Posttraumatic Stress Disorder
  • Major Depressive Disorder
  • Behavioral Activation
  • Cognitive Processing Therapy
  • San Diego, California
    Naval Medical Center San Diego
Apr 4, 2022

MDD Trial in United States (SAGE-217, Placebo)

Terminated
  • Major Depressive Disorder
  • Bentonville, Arkansas
  • +45 more
Oct 15, 2021

Depression, MDD Trial in United States (AXS-05, Placebo)

Completed
  • Depression
  • Major Depressive Disorder
  • Phoenix, Arizona
  • +42 more
Sep 22, 2021

MDD Trial in Worldwide (SPD489 (Lisdexamfetamine dimesylate) + Antidepressant)

Terminated
Has Results
  • Major Depressive Disorder
  • SPD489 (Lisdexamfetamine dimesylate) + Antidepressant
  • Birmingham, Alabama
  • +211 more
Jun 9, 2021

MDD Trial in United States (Antidepressant + SPD489 (lisdexamfetamine dimesylate), Antidepressant + )

Completed
Has Results
  • Major Depressive Disorder
  • Antidepressant + SPD489 (lisdexamfetamine dimesylate)
  • Antidepressant + placebo
  • Newport Beach, California
  • +14 more
Jun 8, 2021

MDD Trial in Worldwide (Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 10 mg, Antidepressant + SPD489 (Lisdexamfetamine

Completed
Has Results
  • Major Depressive Disorder
  • Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 10 mg
  • +4 more
  • Little Rock, Arkansas
  • +81 more
May 25, 2021

MDD Trial in United States (CP-601,927, Placebo)

Terminated
Has Results
  • Major Depressive Disorder
  • Little Rock, Arkansas
  • +57 more
Apr 7, 2021

MDD Trial in San Diego (Physical Activity-based Interventions)

Completed
  • Major Depressive Disorder
  • Physical Activity-based Interventions
  • San Diego, California
    Naval Medical Center San Diego
Mar 10, 2021

MDD Trial in United States (Vortioxetine, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • Phoenix, Arizona
  • +78 more
Dec 16, 2020

MDD Trial in Puerto Rico, United States (AGO178)

Terminated
  • Major Depressive Disorder
  • Birmingham, Alabama
  • +97 more
Dec 16, 2020

MDD Trial in Puerto Rico, United States (Agomelatine (AGO178C), Placebo)

Completed
  • Major Depressive Disorder
  • Agomelatine (AGO178C)
  • Placebo
  • Birmingham, Alabama
  • +44 more
Dec 16, 2020

MDD Trial in Puerto Rico, United States (agomelatine, )

Completed
  • Major Depressive Disorder
  • Scottsdale, Arizona
  • +43 more
Dec 15, 2020

MDD Trial in Puerto Rico, United States (Agomelatine (AGO178C), Placebo)

Completed
  • Major Depressive Disorder
  • Agomelatine (AGO178C)
  • Placebo
  • Birmingham, Alabama
  • +47 more
Dec 15, 2020

MDD Trial in Puerto Rico, United States (Agomelatine, paroxetine, )

Completed
  • Major Depressive Disorder
  • Phoenix, Arizona
  • +46 more
Dec 15, 2020

MDD Trial in United States (Assay-guided treatment (AGT), Treatment-as-usual (TAU))

Completed
Has Results
  • Major Depressive Disorder
  • Assay-guided treatment (AGT)
  • Treatment-as-usual (TAU)
  • Birmingham, Alabama
  • +22 more
Aug 27, 2020